The importance of the amyloid precursor protein (APP) in the pathogenesis of Alzheimer's disease (AD) became apparent through the identification of distinct mutations in the APP gene, causing early onset familial AD with the accumulation of a 4-kDa peptide fragment (␤A4) in amyloid plaques and vascular deposits. However, the physiological role of APP is still unclear. In this work, Drosophila melanogaster is used as a model system to analyze the function of APP by expressing wild-type and various mutant forms of human APP in f ly tissue culture cells as well as in transgenic f ly lines. After expression of full-length APP forms, secretion of APP but not of ␤A4 was observed in both systems. By using SPA4CT, a short APP form in which the signal peptide was fused directly to the ␤A4 region, transmembrane domain, and cytoplasmic tail, we observed ␤A4 release in f lies and f ly-tissue culture cells. Consequently, we showed a ␥-secretase activity in f lies. Interestingly, transgenic f lies expressing full-length forms of APP have a blistered-wing phenotype. As the wing is composed of interacting dorsal and ventral epithelial cell layers, this phenotype suggests that human APP expression interferes with cell adhesion͞signaling pathways in Drosophila, independently of ␤A4 generation.
The amyloid precursor protein (APP) is a ubiquitously expressed, integral membrane protein (1, 2) . APP belongs to a protein family with two other members in mammals: the amyloid precursor-like protein 1 and 2 (APLP1 and APLP2, refs. [3] [4] [5] . The central role of APP in the pathogenesis of Alzheimer's disease (AD, ref. 6 ) and its evolutionary conservation suggest important biological functions for the protein.
Two homologues have been found in invertebrates: the amyloid protein-like protein 1 (APL-1) in Caenorhabditis elegans (7) and the amyloid precursor protein-like protein (APPL) in Drosophila melanogaster (8) . Flies deficient for expression of APPL show phototaxis impairment and can be rescued by the expression of human APP (9) . None of the homologous members of the APP protein family exhibit sequence similarities within the ␤-amyloid region of APP that encodes the characteristic 4-kDa proteinaceous component in vascular deposits and amyloid plaques of AD, ␤A4 (6) . The ␤A4 peptide is cleaved from APP by unknown proteases termed ␤-secretase, which generates the N terminus and ␥-secretase, which releases the C terminus by cleaving within the transmembrane domain of APP. Differential cleavage by ␥-secretase produces ␤A4 of 40 or 42 amino acid residues in length with the 42-aa peptide being increased by distinct mutations in the APP and presenilin genes causing early onset familial AD (reviewed in ref. 6) . A third cleavage of APP by ␣-secretase occurs within the ␤A4 domain and precludes ␤A4 formation.
The 110-to 130-kDa ectodomain of APP generated by ␣-or ␤-secretase is secreted into the extracellular space.
Despite the availability of APPL-deficient flies (9) , APPnull mutants, or transgenic mice expressing human APP (10) (11) (12) , the physiological role of APP remains obscure. The structure of APP indicated a possible function as receptor (1) involved in cell-cell and cell-matrix adhesion. The discovery and characterization of cytoplasmic APP-binding proteins such as Fe65 and X11 support a possible signaling-receptor function for APP (13) . It has also been suggested that secreted APP forms may function as growth factors in fibroblasts (14) or as mediators of neurite outgrowth in PC12 cells (15) .
In this study, we investigated the processing of APP in insect cells and the role of ␤A4 in APP function in transgenic D. melanogaster. By analyzing the processing of APP and its derivatives, we were able to establish a ␥-secretase activity in insects. Depending on the gene expression of full-length APP and the derivatives thereof, we obtained a distinct blisteredwing phenotype in transgenic flies, independent of ␤A4 production, suggesting a physiological function of APP in the regulation of cell-cell adhesion. (19) , and (v) chimeric APP695͞APLP2-N-myc. For the latter construct, the BglIIClaI fragment covering the ␤A4 region and the entire C terminus of APP695 was replaced by the homologous region of APLP2. To introduce the BglII and ClaI restriction sites in APLP2, a corresponding fragment was amplified by PCR with the following primers: APLP2-s-BglII (GGAAGATCTC-CGATGT TA AGGA A ATGAT T T) and A PLP2-as-ClaI (CCCATCGATGGGATCTTCCGGCCCACCTGC). The products were shown to be correct by sequencing. The c-myc encoding epitope (EQKLISEEDL) was inserted into the constructs as described (ref. 19 ; Fig. 1 ). The pUAST vector and the APP695-constructs were linearized with NotI and KpnI by partial digestion and ligated.
MATERIALS AND METHODS

DNA
Transient Transfection of Schneider Cells SL-2. A D. melanogaster embryonic cell line, Schneider cells SL-2 (20) grown in Schneider's medium at 25°C, was transfected tran-siently with Lipofectin, according to the manufacturer's protocol (GIBCO͞BRL). The expression of the different APP forms in the pUAST vector was induced on cotransfection with a vector expressing the yeast transactivator GAL4 under control of the actin promoter (21) . Transiently transfected SL-2 cells were cultured on 10-cm dishes and usually harvested after 48 h. Cells were lysed in 500 l of lysis buffer (50 mM Tris⅐HCl, pH 7.5͞150 mM NaCl͞1% Nonidet P-40, vol͞vol). Complete protease-inhibitor mixture (Boehringer Mannheim) was added according to the manufacturer's protocol. Cell lysates and conditioned medium (CM) were investigated in immunoprecipitations and Western blot analyses (19, 22) .
Transgenic Fly Lines. Strains Oregon R as wild-type control and the transformation host white (w 1118 ) were raised on standard fly food at 18°C or 25°C with 60-70% relative humidity. Each of the APP695-constructs described above was coinjected with the helper vector pUChs⌬2-3 into w 1118 embryos. Transformants were selected, and lines with singlecopy inserts were established. Transgenic lines were mated with different GAL4 driver strains. For extract preparations, 5-10 flies or 10 fly bodies and 100 fly heads were homogenized separately in 1.5-ml reaction tubes with a micropestle in 500 l of RIPA buffer [50 mM Tris⅐HCl, pH 8.0͞1% SDS (wt/vol)͞ 0.5% sodium deoxycholate (wt/vol)͞1% Triton X-100 (vol/ vol)͞150 mM NaCl]. Complete protease-inhibitor mixture (Boehringer Mannheim) was added according to the manufacturer's protocol. After homogenization, the fly debris was centrifuged at 18,000 ϫ g, and the supernatant was loaded directly on a gel or used for immunoprecipitation.
Immunoprecipitation and Western Blotting. For detection of APP695, APP695-Swedish, APP695 ⌬CT-N-myc, and chimeric APP695͞APLP2-N-myc (the full-length APP695 derivatives) cell lysates, CM, and fly homogenates were immunoprecipitated with polyclonal antiserum FdAPP (22) . For detection of SPA4CT-C-myc cell lysates, CM and f ly homogenates were immunoprecipitated with polyclonal antiserum A4CT (18) . ␣-Secretory APP695 was immunoprecipitated with mAb W0-2 (23) from CM of transfected SL-2 cells. ␤A4 was immunoprecipitated with mAbs W0-2, G2-10 (23), and 4G8 (24) and with polyclonal rabbit antisera 692 and 24-224 (obtained from G. Multhaup, University of Heidelberg). Expressed constructs carrying a myc tag were immunoprecipitated in cell-culture CM or in cell lysates (C-terminal myc tag) with polyclonal anti-myc antiserum (Eurogentec, Brussels). Immunoprecipitations with mAbs were performed in the presence of protein G-agarose. With polyclonal sera (Boehringer Mannheim), protein A-Sepharose (Pharmacia) was used according to the manufacturer's protocol. Precipitates of full-length APP695 derivatives were analyzed on SDS͞7.5% PAGE, and precipitates of SPA4CT-C-myc and of ␤A4 were analyzed on SDS͞16.5% PAGE. For Western blotting, full-length APP695 derivatives were transferred to 0.45-m nitrocellulose membranes at 190 mA for 4 h, and SPA4CT-C-myc and ␤A4 were transferred to 0.45-m nitrocellulose membranes at 380 mA for 45 min. To enhance the ␤A4 signal, the nitrocellulose membrane was boiled in PBS for 5 min as described (23) . Full-length APP695 derivatives were visualized with mAb 22C11 (22), and SPA4CT-C-myc and ␤A4 were visualized with mAb W0-2 (23), all with the enhancedchemiluminescence detection system (Amersham).
RESULTS
APP695 and Derivatives Expressed in Drosophila Schneider
Cell Culture. To analyze APP expression and metabolism in the Drosophila system, we transiently expressed wild-type human APP and mutant derivatives in SL-2 tissue-culture cells. The different forms used in this study are depicted in Fig. 1 . To express the various APP forms, SL-2 cells were cotransfected with pP AC ͞GAL4 expressing the yeast transcriptional activator GAL4 under the control of a strong actin promoter. Immunoprecipitations of cell lysates with the APP-specific polyclonal antiserum FdAPP (22) showed expression of APP695, APP695-Swedish, APP695⌬CT-N-myc, and the chimeric APP695͞APLP2-N-myc construct in SL-2 cells, whereas nontransfected cells were devoid of signals (Fig. 2 ).
After immunoprecipitations with mAb W0-2 of CM, secreted APP695, APP695-Swedish, and APP695⌬CT-N-myc became readily detectable (Fig. 2) . The APP695⌬CT-N-myc band was shifted slightly to a higher molecular mass because of the myc tag. Because antibody W0-2 recognizes amino acids 5-9 from the ␤A4, secretory forms of APP produced by ␤-or the recently postulated ␦-secretase (25) could not be detected. ␣-Secreted APP695, produced mainly by cleavage C-terminal to lysine residue 16 of ␤A4, is detectable with mAb W0-2. As expected, cells transfected with the chimeric APP695͞APLP2-N-myc and nontransfected SL-2 cells did not give rise to bands with W0-2 ( Fig. 2) . APP695͞APLP2-N-myc thus served as an internal antibody control, because it lacks the ␤A4 domain recognized by W0-2. By analyzing CM of cells expressing this construct with polyclonal serum FdAPP, we also detected secretion (data not shown).
SPA4CT-C-myc Expressing SL-2 Cells Release a 4-kDa Peptide Detectable with ␤A4-Specific Antibodies. Because the production of ␤A4 from full-length APP indicates the presence of ␤-and ␥-secretase, and production of ␤A4 from SPA4CT indicates ␥-secretase activity (18), we analyzed the ␤A4 content in CM of SL-2 cells expressing the full-length APP derivatives and SPA4CT-C-myc by using ␤A4-specific antibodies for immunoprecipitations. No ␤A4 was detectable in CM of SL-2 cells expressing A PP695, A PP695-Swedish, APP695⌬CT-N-myc, or chimeric APP695͞APLP2-N-myc. However, ␤A4 was readily detectable as a 4-kDa band in immunoprecipitates of CM from SL-2 cells expressing SPA4CT-C-myc (Fig. 3) . The same 4-kDa band was obtained with different ␤A4-specific mAbs (Fig. 1) , polyclonal serum Fig. 3A) , polyclonal serum 24-224 (Fig. 3B) , and mAb G2-10 ( Fig. 3B) , suggesting that this band represents ␤A4 secreted by the insect cells. This band was not detected in CM of nontransfected cells (Fig. 3) or of cells transfected only with the vector pP AC ͞Gal4.
(
The major ␤A4 species produced by the insect cells was the 40-aa peptide as shown by immunoprecipitation with our 40-specific mAb G2-10 ( Fig. 3B) . ␤A4 peptides ending at residue 42, however, could not be detected with our 42-specific mAb G2-11 (data not shown). Therefore, the major ␤A4 form produced by insect cells seems to end after 40 aa. If the 42-aa species was also produced, the amounts were below our detection limit (23) .
Transgenic Drosophila Expressing APP695 and Derivatives. A well established method to modulate the expression of transgenes subcloned into the pUAST vector in Drosophila is to cross these flies with fly lines transgenic for a particular GAL4 driver (16) . In this study, we used mainly the GAL4-strain Mz-1087.hx, in which the expression of transgenes occurs preferentially during larval stages in salivary glands, midgut, and imaginal discs including the wing discs (kindly obtained from J. Urban and G. Technau, University of Mainz, Germany). The wing discs show a rather homogenous expression of GAL4. In adult flies, expression of GAL4 transgenes was strongest in fly heads.
Transgenic Drosophila were investigated for the expression of APP695 and derivatives after crossing with the GAL4-strain Mz-1087.hx. Homogenates (soluble fraction) of 5-10 flies were analyzed directly on SDS͞PAGE. In Fig. 4A , we show high protein-expression levels of APP695 (WT-34, WT-35) and APP695-Swedish (S5, S6) for two different transgenic fly lines. In contrast, controls (wild-type flies) showed no APP band. For each construct, we always assessed at least two different lines for transgene expression. Strong expression of APP695͞ APLP2-N-myc and APP695⌬CT-N-myc could also be detected in transgenic flies (Fig. 4B) . The corresponding bands were absent in extracts of wild-type flies (Fig. 4B) . The APP bands shown in Fig. 4 A and B appear to be double bands and may represent differences in glycosylation, which occurs in insect cells but to a lesser extent than in mammalian cells (26) . SPA4CT-C-myc was also expressed in transgenic flies (Fig.  4C) .
Transgenic Drosophila Expressing SPA4CT-C-myc Release a 4-kDa Peptide Detectable with Anti-␤A4 Antibodies. Because one aim of this study was to investigate whether insects are able to produce ␤A4 from human APP, we tested all transgenic lines for ␤A4 release by using homogenized flies, fly heads, larvae, or embryos. Flies transgenic for APP695͞ APLP2-N-myc and wild-type flies served as controls. ␤A4 could not be detected in lines expressing APP695, APP695-Swedish, or APP695⌬CT-N-myc by direct SDS͞PAGE or by SDS͞PAGE of immunoprecipitates (data not shown), confirming our observations made with SL-2 cells. However, we found, as we did in transfected SL-2 cells, that flies expressing SPA4CT-C-myc produce ␤A4 (Fig. 5) . We separately investigated homogenates from fly heads and bodies by immunoprecipitation with mAbs G2-10, W0-2, and 4G8, which are specific for three different regions of ␤A4 (Fig. 1) . In immunoprecipitations of fly-head homogenates, all three antibodies yielded the same 4-kDa peptide band (Fig. 5, tH) , which showed the same electrophoretic mobility as synthetic ␤A4. The same band was also present, although weakly, in fly-body homogenates (tB). In the wild-type controls (wH), bands of comparable size were not detectable. SPA4CT-C-myc protein could be visualized with mAbs 4G8 (tH, tB) and W0-2 (tH) as a band migrating below the 18.4-kDa protein marker. Immunoprecipitation with mAb W0-2 showed one additional band in the range between 14 and 18 kDa in fly heads and bodies, which seems to be a C-terminal shortened breakdown product of SPA4CT (tH, tB). In addition, W0-2 precipitated from fly (22) . The lower protein band shows a higher molecular mass than APP and derivatives, and it might represent bovine APP from the fetal calf serum that was supplied to the media. At least mAb W0-2 is able to detect bovine ␤A4 from fetal calf serum (data not shown). bodies (tB) a distinct 8-kDa protein band, which may represent a caspase cleavage product of SPA4CT-C-myc. Transgenic Drosophila Expressing Full-Length APP Derivatives Develop a Blistered-Wing Phenotype. During the establishment of transgenic flies expressing APP, we noted that, in certain lines, wing abnormalities were independent of the site of integration but dependent on the transgene. The most striking result was a dominant blistered-wing phenotype that occurred only in f lies transgenic for APP695, APP695-Swedish, and APP695͞APLP2-N-myc. These flies develop a wing deformation in one or both wings. Large blisters often occupied Ͼ50% of the wing surface (Fig. 6) . In extreme cases, wings were formed like balloons (Fig. 6 B) . The blisters appear transparent or black, were filled with hemolymph, and occurred in 5-20% of transgenic animals that were raised at a temperature of 25°C. The pattern of the wing veins remained normal. To assess whether this phenotype was specific for the Mz-1087.hx line, we crossed the APP695͞APLP2-N-myc with different GAL4-expressing driver lines that have been described (16) . Lines expressing GAL4 in the wing disc always had wing blisters (Table 1 ). This phenotype points to a dysfunction in cell-cell adhesion between the two epithelial cell layers forming the fly wing (27) . We observed no other obvious phenotypic consequences in these lines, although some combinations show a decreased viability.
Lines with a C-terminally truncated protein (APP695⌬CT-N-myc) showed no blistered-wing phenotype. This result cannot be attributed to a lower level of protein expression in these lines, as corresponding immunostainings of imaginal discs showed a protein level comparable to that of lines expressing full-length forms of APP (data not shown). Similarly, flies transgenic for SPA4CT-C-myc did not develop a blisteredwing phenotype. Because these are the only flies with detectable production of ␤A4, we assume that the wing blisters are independent of ␤A4 production. Additionally, flies expressing APP695͞APLP2-N-myc do not possess a ␤A4 region, but these flies still show distinct wing blisters, establishing that the ␤A4 region is not essential for this phenotype. Immunoprecipitates of soluble homogenates from 100 wild-type fly heads (wH), 100 transgenic fly heads (tH), and 10 transgenic fly bodies (tB) with mAb G2-10, W0-2, and 4G8 are shown after SDS͞16.5% PAGE in an immunoblot detected with mAb W0-2. A 4-kDa ␤A4 was precipitated with mAb G2-10 (tH), mAb W0-2 (tH), and mAb 4G8 (tH). The 4-kDa band is in the same range as synthetic ␤A4 (500 pg). Expression of SPA4CT-C-myc was detectable as an 18-kDa band with antibodies mAb W0-2 (tH, tB) and mAb 4G8 (tH).
DISCUSSION
In the present study, transgenic D. melanogaster was established as a model to analyze basic functions of human APP695. By using this fly system, we were able to show the processing of APP by ␣-and ␥-secretase. Additionally, we observed a rather intriguing wing phenotype in certain transgenic fly lines, pointing to interesting functions of APP in vivo. Secreted APP695 forms had already been produced in Spodoptera frugiperda (Sf9) insect cells infected with APP-recombinant baculoviruses (28) . In this system, secretion of the N-terminal APP ectodomain fragment was caused by ␣-cleavage within the ␤A4 sequence C-terminal to glutamine-15 or lysine-16. The C-terminal counterpart of this cleavage was isolated from mammalian cells and started with ␤A4-residue leucine-17 (29) . These data confirmed processing of APP in Sf9 cells identical to that in mammalian cells. Similarly, for APPL, the endogenous fly homologue of APP, a secretion was observed in primary cell cultures of embryos and in SL-2 cells (9) .
We analyzed the cleavage site in the APP ectodomain with antibody W0-2. This antibody recognizes residues 5-9 of the ␤A4 region. Because we were able to detect secreted APP in CM of transfected SL-2 cells with mAb W0-2, the secretory cleavage occurred C-terminal of residue 9 of the ␤A4 region that would be compatible with cleavage by ␣-secretase. Cleavages by ␤-or ␦-secretase occur N-terminal of the W0-2 epitope and were therefore excluded (25) . Additionally, we specifically addressed the question of whether amyloidogenic processing occurs in flies transgenic for human APP and whether ␤A4 release is detectable. Although this has not been observed yet (30) , we clearly show that in transfected SL-2 cells and in flies transgenic for SPA4CT-C-myc, a 4-kDa ␤A4 band, recognized by different ␤A4-specific antibodies after immunoprecipitation, is produced. As we were not able to detect this 4-kDa peptide as a direct cleavage product from full-length APP695 and its derivatives, we assume that the postulated ␤-secretase might somehow be altered in insects or might cleave APP to a nondetectable extent. Because, in mammalian cells, SPA4CT-C-myc is processed by signal peptidase to A4CT-Cmyc, which begins with the N terminus of ␤A4, a single ␥-secretase cleavage was sufficient to release ␤A4 from the A4CT-C-myc stub (18) . As the signal peptide of human APP695 was recognized and properly cleaved in Sf9 cells (28) , detection of ␤A4 in CM of SL-2 cells and homogenates of transgenic flies expressing SPA4CT strongly suggests the presence of ␥-secretase activity in Drosophila. By using antibodies that specifically react with the C-terminal eight amino acid residues of ␤A4 1-40 (G2-10) or ␤A4 1-42 (G2-11), respectively, we identified ␤A4 1-40 as the major form produced in this system. ␤A4 1-42 was either not produced or produced at levels below the detection limits of G2-11 (23) .
Flies transgenic for the full-length APP forms of APP695, APP695-Swedish, and chimeric APP͞APLP2-N-myc developed a striking blistered-wing phenotype. This phenotype is not caused by position effects; different integrants for a given construct showed the same effects. In addition, the phenotype cannot be caused by mutations in wing-specific genes induced by the integration of the transgenes. Homozygous lines lacking the GAL4 driver never exhibited the wing phenotype, and only after GAL4-induction in appropriate lines and crosses was a wing phenotype observed. We also do not consider it very likely that the wing phenotype is an unspecific effect caused by the overproduction of a transmembrane protein. Lines, like APP⌬CT-N-myc, expressed comparable amounts of membrane APP but did not produce the phenotype. This construct showed also that in addition to the ectodomain and transmembrane domain, the cytoplasmic domain of APP is necessary for blistered-wing formation. The latter may indicate that a transmembrane signaling function of APP is imposed on the blistered-wing phenotype in a dominant function presumably by interacting and inhibiting an appropriate partner on the cell membrane.
We suggest that the blistered-wing phenotype resulting from ectopic APP expression in Drosophila reflects a physiological function of APP in the regulation of cell adhesion and signaling. Wing morphogenesis in Drosophila is characterized by two periods of apposition and separation of the dorsal and a ventral cell layer of the wing before the epithelia become fused permanently (31) . We presume that APP negatively interacts with factors involved in the adhesion of the two epithelia during wing development. In Drosophila, several mutations affecting wing morphology, and particularly the adhesion of the two epithelial cell layers, have been isolated. Mutant flies deficient for the expression of most integrin subunits develop distinct wing blisters. Integrins are heterodimeric receptors that may be ligand-bound to extracellular matrix components and may have a signaling function (32) . Fly integrins are especially required for the function of the cell-matrix-cell junction, where one surface of the developing wing adheres to the other (33) . This function of integrins supports our suggestion of APP's involvement in cell adhesion. In this context, APP might be an antagonist for integrins, such that APP would bind, either directly or via other components, the same extracellular matrix components as integrins. Indeed, recent investigations in primary rat neurons confirmed a colocalization of APP and integrins (34, 35) . The phenotype we observed in Drosophila might be caused by a specific interaction of human APP with evolutionarily conserved protein partners, resulting in a deterioration of the adhesion͞signaling pathway supported by the integrins. A particularly intriguing result in this context is the recent finding that one of the integrin subunits is involved in short-term memory in Drosophila (36), thus, potentially uncovering an interesting link between basic APP functions, integrin-mediated adhesion processes, and memory mechanisms. However, other pathways have to be considered. For example, expression of a mutant form of a G protein involved in cAMP signaling results in a comparable phenotype (37) . Similarly, the blistered gene, encoding a protein related to human serum-response factor (38) , represents an additional candidate for a pathway in which APP might be involved.
Thus, Drosophila seems to be a formidable animal-model system for studying basic functions of human APP and may be suited for studying APP transmembrane signaling mechanisms potentially related to AD. The ␣-and ␥-secretase activities described here establish the usefulness of Drosophila as a model system for isolating the unknown secretases. Additionally, possible inhibitors of ␥-secretase might be tested more efficiently in the fly system; these inhibitors may become therapeutic tools in diminishing the deleterious effects of ␤A4 generation in AD. To analyze physiological functions of APP, the fly model seems especially suitable, because we can find a specific phenotype depending on the ectopic expression of full-length APP. Thus, the possibility of testing genetic interactions between APP-expressing lines and the comparable mutants engaged in wing morphology should allow us to uncover the biological pathways affected by human APP. 
